Search - tctmd.com

Displaying 101 - 120 of 127

Sort: Relevancy | Date

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

Presentation TCT 2013

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Presenter: Joe Dizon, Sorin Brener, Akiko Maehara, Bernhard Witzenbichler, Jacek Godlewski, Helen Parise, Jan-Henk Dambrink, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Presenter: David Planer, E. Magnus Ohman, Harvey White, Jeffrey Moses, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Presenter: Magdi El-Omar, Sorin Brener, Akiko Maehara, Thomas Scott, Roxana Mehran, Wim Aengevaeren, Dariusz Dudek, Martin Fahy, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Presenter: Benoit Daneault, Philippe Genereux, Ajay Kirtane, Bernhard Witzenbichler, Giulio Guagliumi, Jean-Michel Paradis, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene, Philippe Genereux, Michael Ezekowitz, Ajay Kirtane, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Presenter: Akiko Maehara, Gary Mintz, Sorin Brener, Jan-Henk Dambrink, Magdi El-Omar, Anthony Gershlick, Martin Fahy, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Jason Kahn

December 03, 2012

News Daily News

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Jason Kahn

December 03, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

A View to Future Trials: HORIZONS-AMI II and Others

Presenter: Roxana Mehran

October 24, 2012

Presentation TCT 2012

Choice of Antiplatelet Therapies in ACS/STEMI

Presenter: Roxana Mehran

October 22, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Presenter: Rudolf Jarai, Kurt Huber, Ke S. Xu, Bimmer Claessen, Georg Dangas, Roxana Mehran, Gregg Stone

January 03, 2012

Advertisement

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

A View to Future Trials: HORIZONS-AMI II and Others

Choice of Antiplatelet Therapies in ACS/STEMI

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Oral Antiplatelet Agents in PCI and ACS

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content